subject area of
- A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes Journal Articles
- Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications Journal Articles
- Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention Journal Articles
- Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease Journal Articles
- Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease? Journal Articles
- BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase Journal Articles
- Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT) Journal Articles
- Clopidogrel in acute coronary syndromes: Where are we now? Journal Articles
- Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Journal Articles
- Complete Revascularization with Multivessel PCI for Myocardial Infarction Journal Articles
-
Contemporary use of
guideline‐based higher potencyP2Y12 receptor inhibitor therapy in patients withmoderate‐to‐high risknon‐ST‐segment elevation myocardial infarction: Results from the CanadianACS reflectiveII cross‐sectional study Journal Articles - Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention Journal Articles
- Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI Journal Articles
- Evidence that 5‐HT stimulates intracellular Ca2+ signalling and activates pannexin‐1 currents in type II cells of the rat carotid body Journal Articles
- Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes Journal Articles
- Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention Journal Articles
- Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy Journal Articles
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Journal Articles
- Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy Journal Articles
- New antithrombotic agents—insights from clinical trials Journal Articles
- Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial Journal Articles
- P2Y12 receptor inhibitor resistance and coronary artery disease Journal Articles
- Platelet Transfusion for Ticagrelor Reversal Journal Articles
- Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation Journal Articles
- Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD) Journal Articles
- Reply to ‘Concerns about 2015 ERC Guidelines on pre-hospital use of ADP-receptor antagonists in patients with STEMI (ACS 335)’ Journal Articles
- Role of phenotypic and genetic testing in managing clopidogrel therapy Journal Articles
- Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis Journal Articles